In France, the vaccination campaign against papillomavirus (HPV) begins on October 2 in around 7,000 middle schools, targeting 5th grade students.
Less than half of adolescents in France have already received this vaccine, while in Sweden more than 80% have done so. The vaccine is strongly recommended by the Ministry of Health for boys and girls aged 11 and over, because it protects against HPV responsible for certain cancers (uterus, vagina, penis, throat). Unfortunately, there are misconceptions that the vaccine is ineffective or causes serious side effects. Certain religious reasons also lead to reluctance.
In 2010, a high-profile case involving symptoms similar to multiple sclerosis raised concerns, but the courts ultimately dismissed the complaint. In July, a collective also called for a moratorium, alleging that HPV vaccines cause an unrecognized disease, macrophage myofasciitis.
Additionally, many parents are unaware of the vaccination recommendation, according to a 2022 study showing that half of those surveyed were unaware of the vaccine, and a 2015 study finding that most doctors were not talking about it systematically.
 Pascal Lemontel
|
02/10/2023 | 
| 
Anglais
Arabic
Deutsch
Français
Español
Italien
Português
Russian